Raising Red Flags: A Closer Look at RH’s Pattern of Overly Optimistic Guidance

Antimonopoly Groups Push for Corporate Probes, Antitrust Bills if Jamie Raskin Takes House Judiciary Committee Gavel Next Year

Antimonopoly advocates are taking Representative Jamie Raskin at his word when he says he plans to conduct aggressive investigations into the Trump administration’s handling of antitrust...

Health Care Weekly: Liquidia Drug Marketing for Lung Condition Found to Violate Rival’s Patent After ‘At-Risk’ Launch; CMS Slashes Scope of GLOBE Pricing Model; FDA Seeks Input on Psychedelic Made From Tree Bark; Medline Hospital Bed Recall Tops 1 Million; GAO Report Says Vertical Integration in Pharmacy Saves Patients Money; FTC Presses Hospitals to Post Prices; HHS Seeks to Speed Drug Trials

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...

Life & Annuity Industry: Regulators Seek Visibility into Potential Solvency Risks Posed by Funding Agreement-Backed Notes

The rapid emergence of funding agreement-backed notes (FABNs), which have helped to fuel life insurers’ investments in private credit, is drawing scrutiny from the National Association of Insurance...